NEW YORK — Tangen Biosciences said on Friday that it has signed an exclusive agreement under which its GeneSpark point-of-care instrument will be distributed as part of LabWare's portable disease surveillance kit for SARS-CoV-2.
NEW YORK — Tangen Biosciences said on Friday that it has signed an exclusive agreement under which its GeneSpark point-of-care instrument will be distributed as part of LabWare's portable disease surveillance kit for SARS-CoV-2.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.
Privacy Policy. Terms & Conditions. . Copyright © 2021 GenomeWeb, a business unit of Crain Communications. All Rights Reserved.